TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice.
about
Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm developmentAccentuating and Opposing Factors Leading to Development of Thoracic Aortic Aneurysms Not Due to Genetic or Inherited ConditionsIGF-1, oxidative stress and atheroprotectionTGFB1 genetic polymorphisms and coronary heart disease risk: a meta-analysisPlatelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload.Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient miceElevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) miceMacrophage death and defective inflammation resolution in atherosclerosis.99mTc-labeled bevacizumab for detecting atherosclerotic plaque linked to plaque neovascularization and monitoring antiangiogenic effects of atorvastatin treatment in ApoE-/- miceSmooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stabilityInteraction between insulin-like growth factor-1 and atherosclerosis and vascular aging.Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.Regulation of ADAMTS-1, -4 and -5 expression in human macrophages: differential regulation by key cytokines implicated in atherosclerosis and novel synergism between TL1A and IL-17.T cell-specific overexpression of TGFß1 fails to influence atherosclerosis in ApoE-deficient miceA mechanism by which dietary trans fats cause atherosclerosis.Attenuated atherosclerotic lesions in apoE-Fcγ-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells.Dihydroaustrasulfone Alcohol (WA-25) Impedes Macrophage Foam Cell Formation by Regulating the Transforming Growth Factor-β1 Pathway.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Aging, atherosclerosis, and IGF-1Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix RemodelingVascular complications of diabetes: mechanisms of injury and protective factorsPostnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in MicePossible mechanical roles of glycosaminoglycans in thoracic aortic dissection and associations with dysregulated transforming growth factor-β.Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- miceAbrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis.Transforming growth factor (TGF)-β signaling in cardiac remodeling.Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.Molecular biology of atherosclerosis.T lymphocytes and aortic aneurysms.Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.The immunology of atherosclerosis.Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury.The role of shear-induced transforming growth factor-β signaling in the endothelium.Transforming growth factor-β: transforming plaque to stabilityTransforming Growth Factor-β1 Inhibits Pseudoaneurysm Formation After Aortic Patch Angioplasty.Regulatory T cells as a new therapeutic target for atherosclerosis.7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events
P2860
Q24303139-B51F203B-2F6B-47D8-B8D9-EE4A6BDA73D2Q26776128-12D22083-0D3F-48CE-919B-363D951BE623Q27694593-D1D325AC-C049-46B3-B5BF-20F108F365F3Q28712812-A892FC5C-69C7-46E3-B12E-FEA683CE3CD7Q30504664-C20F81D9-68C5-4696-A0B3-181ECCB04AA8Q31075609-3A7674FE-5CC0-4A5F-8C58-F7C8878DC02CQ33590493-5DB1C391-8857-46AA-8B85-6F26EDF077DFQ33789327-CA8FCE05-4710-4FF0-9062-ED6E927973FAQ33799297-C195E936-B47B-4C5F-A6CE-618FF7BDC1E5Q34134537-E636B674-3E6C-4A71-9480-32398EB6649AQ34349858-2D245293-347D-47C1-844B-EBA8DD2FA3D6Q34506416-BF6AD251-C41B-436D-9065-E7C1931AE2B7Q34823855-C5C2BC53-22AF-4278-A27E-1A71FA872FA9Q35067512-FDFE6B15-3B75-4BEF-ABD3-E16C5EBF0022Q35073404-8FE933A0-C49E-4443-9319-F722E8A61D71Q35566640-960FD10A-DD56-4AF5-95D0-FFA53FF4965AQ35626888-4497E898-217E-49AB-90E7-779B01B53157Q35640438-CC777F7A-5431-468F-B977-F0FDAA7F983DQ35947440-3AFF6FE2-E7EE-47AB-A191-BBB37A3AF421Q36403328-E474C1AF-BDED-4903-B8D7-7104501EED92Q36537262-E5F30E55-17C5-4592-BED1-92501F27531AQ36551449-ACC3BF8C-5C01-4247-894D-CAA80603C825Q36714324-837AF56F-5662-4584-B866-1A78D75C440AQ37002708-272C0855-7C38-4678-A424-A40131B9AA6CQ37407750-C4159432-244E-4B29-BB4E-96577160A83DQ37524234-D3C7E916-2199-4FCD-97AB-D9AB9161069BQ37808014-308C0BCF-EC62-4C52-AC03-7D71A841E916Q37882523-74609EE6-7FB7-4C50-901B-02FB7F35D8DEQ38125279-4538DBF9-E350-4CAC-A37B-5E4672E329B1Q38238026-2550E273-55ED-47C4-AE30-6C5240C5352EQ38620803-9AFE7711-EF84-4D63-9614-E20153D724DBQ39230390-105EC691-58DE-4F16-9158-51A8BFE1B830Q41831221-709B1AC7-E263-4D86-A6B3-283B2C8157A7Q41996789-89B3F95E-18C8-460F-ADEA-E29885E89660Q42571045-B6798551-EF94-428D-85BC-5E30156A1C63Q47340304-49044D24-70F5-4282-8453-5A9D9D5A8E71Q50093330-30AD3B6F-61A9-4777-9665-CCAD66AEC7AEQ51318688-234B80B3-7866-4EE2-BC46-FE5BCE08824DQ57414509-E14E9F6A-5023-4773-9F61-0E4E0A61D63E
P2860
TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TGF-[beta]1 limits plaque grow ...... in apolipoprotein E-null mice.
@en
TGF-[beta]1 limits plaque grow ...... in apolipoprotein E-null mice.
@nl
type
label
TGF-[beta]1 limits plaque grow ...... in apolipoprotein E-null mice.
@en
TGF-[beta]1 limits plaque grow ...... in apolipoprotein E-null mice.
@nl
prefLabel
TGF-[beta]1 limits plaque grow ...... in apolipoprotein E-null mice.
@en
TGF-[beta]1 limits plaque grow ...... in apolipoprotein E-null mice.
@nl
P2093
P2860
P50
P1476
TGF-[beta]1 limits plaque grow ...... in apolipoprotein E-null mice
@en
P2093
April Stempien-Otero
Caroline J Pennington
Casilde Sesti
Daniel Minter
David A Dichek
Goro Otsuka
Helén L Dichek
Jie Hong Hu
Julien C Marie
P2860
P304
P356
10.1161/ATVBAHA.109.186593
P407
P577
2009-03-26T00:00:00Z